Additionally, gene polymorphisms affecting the APOA1 protein, a protein involved in cholesterol re‐uptake by the liver [16], have been shown to affect the severity of dyslipidaemia experienced by adult patients with schizophrenia treated with AAs [17]. The gene discussed is APOA1; the disease is schizophrenia.